Učitavanje...

Development of Coumarin-Based Hydroxamates as Histone Deacetylase Inhibitors with Antitumor Activities

Histone deacetylases (HDACs) have been proved to be promising targets for the treatment of cancer, and five histone deacetylase inhibitors (HDACis) have been approved on the market for the treatment of different lymphomas. In our previous work, we designed a series of novel coumarin-containing hydro...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Molecules
Glavni autori: Zhao, Na, Yang, Feifei, Han, Lina, Qu, Yuhua, Ge, Di, Zhang, Hua
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2020
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7036849/
https://ncbi.nlm.nih.gov/pubmed/32046013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules25030717
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!